Date published: 2026-2-14

1-800-457-3801

SCBT Portrait Logo
Seach Input

KIR3DL2 Activators

KIR3DL2 Activators are a specialized class of chemical compounds designed to specifically target and enhance the activity of the Killer cell Immunoglobulin-like Receptor 3DL2 (KIR3DL2). KIR3DL2 is a transmembrane glycoprotein expressed on the surface of natural killer (NK) cells and a subset of T cells, which are key players in the immune system's ability to recognize and respond to cellular abnormalities. The primary function of KIR3DL2 is to regulate the cytotoxic activity of NK cells through its interaction with specific ligands, including certain human leukocyte antigen (HLA) class I molecules. By engaging with these ligands, KIR3DL2 transmits inhibitory signals that modulate the immune response, maintaining a balance between activation and inhibition to prevent unwanted tissue damage. Activators in this chemical class would work by modulating the signaling pathways associated with KIR3DL2, potentially by increasing its expression, enhancing ligand binding, or by stabilizing the receptor on the cell surface. The aim of these compounds would be to fine-tune the signaling through KIR3DL2, ensuring precise control over NK cell activity.

The process of identifying and characterizing KIR3DL2 Activators involves intricate and highly technical research methodologies. Initial discovery is likely to rely on high-throughput screening of chemical libraries to identify compounds that can selectively interact with KIR3DL2. Such compounds would then undergo rigorous testing to determine the exact nature of their interaction with the receptor. This might involve binding assays to evaluate their affinity for KIR3DL2 and their impact on the receptor's conformation. Further studies could include the use of molecular biology techniques to assess changes in gene expression levels of KIR3DL2 in response to these activators. Moreover, advanced imaging techniques like flow cytometry or confocal microscopy could be employed to visualize the receptor's distribution and density on the cell membrane upon interaction with these compounds. Through these approaches, scientists gain valuable insights into the molecular dynamics governing the activity of KIR3DL2 and the potential for precise modulation by these activators. This research contributes to a broader understanding of immune cell regulation and the complex interplay of signals that govern the immune system's surveillance mechanisms.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Retinoic Acid, all trans

302-79-4sc-200898
sc-200898A
sc-200898B
sc-200898C
500 mg
5 g
10 g
100 g
$66.00
$325.00
$587.00
$1018.00
28
(1)

May modulate immune cell differentiation and lead to changes in the expression of receptors like KIR3DL2.

1α,25-Dihydroxyvitamin D3

32222-06-3sc-202877B
sc-202877A
sc-202877C
sc-202877D
sc-202877
50 µg
1 mg
5 mg
10 mg
100 µg
$220.00
$645.00
$1000.00
$1500.00
$440.00
32
(2)

This active form of vitamin D3 can modulate immune responses, possibly affecting NK cell receptor expression.

5-Azacytidine

320-67-2sc-221003
500 mg
$280.00
4
(1)

A DNA methyltransferase inhibitor that could alter gene expression profiles, possibly including KIR3DL2.

5-Aza-2′-Deoxycytidine

2353-33-5sc-202424
sc-202424A
sc-202424B
25 mg
100 mg
250 mg
$218.00
$322.00
$426.00
7
(1)

Similar to azacytidine, this compound may change DNA methylation status and affect KIR expression.

Sodium Butyrate

156-54-7sc-202341
sc-202341B
sc-202341A
sc-202341C
250 mg
5 g
25 g
500 g
$31.00
$47.00
$84.00
$222.00
19
(3)

As an HDAC inhibitor, it may impact chromatin structure and gene expression, potentially influencing KIR3DL2 levels.

Valproic Acid

99-66-1sc-213144
10 g
$87.00
9
(1)

Another HDAC inhibitor that might alter the expression of genes in NK cells, including those for KIR3DL2.

Lenalidomide

191732-72-6sc-218656
sc-218656A
sc-218656B
10 mg
100 mg
1 g
$50.00
$374.00
$2071.00
18
(1)

An immunomodulatory drug that could affect the expression of various immune receptors on NK cells.

Thalidomide

50-35-1sc-201445
sc-201445A
100 mg
500 mg
$111.00
$357.00
8
(0)

It has immunomodulatory effects and may influence the phenotype of NK cells, including KIR expression.

Bortezomib

179324-69-7sc-217785
sc-217785A
2.5 mg
25 mg
$135.00
$1085.00
115
(2)

This proteasome inhibitor can affect the turnover of many proteins and potentially alter the expression of immune receptors.

Cyclosporin A

59865-13-3sc-3503
sc-3503-CW
sc-3503A
sc-3503B
sc-3503C
sc-3503D
100 mg
100 mg
500 mg
10 g
25 g
100 g
$63.00
$92.00
$250.00
$485.00
$1035.00
$2141.00
69
(5)

An immunosuppressant that can affect the activation and differentiation of T cells, potentially indirectly affecting NK cells.